DK0956855T3 - Immunhæmmende effekter af 8-substituerede xanthin-derivater - Google Patents

Immunhæmmende effekter af 8-substituerede xanthin-derivater

Info

Publication number
DK0956855T3
DK0956855T3 DK98201323T DK98201323T DK0956855T3 DK 0956855 T3 DK0956855 T3 DK 0956855T3 DK 98201323 T DK98201323 T DK 98201323T DK 98201323 T DK98201323 T DK 98201323T DK 0956855 T3 DK0956855 T3 DK 0956855T3
Authority
DK
Denmark
Prior art keywords
substituted
carbon atoms
unsubstituted
phenyl
group
Prior art date
Application number
DK98201323T
Other languages
English (en)
Inventor
Mark Jozef Albert Waer
Piet Andre Maurits M Herdewijn
Wolfgang Pfleiderer
Original Assignee
Leuven K U Res & Dev
Wolfgang Pfleiderer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leuven K U Res & Dev, Wolfgang Pfleiderer filed Critical Leuven K U Res & Dev
Application granted granted Critical
Publication of DK0956855T3 publication Critical patent/DK0956855T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/12—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1, 3, and 7, e.g. caffeine
DK98201323T 1998-04-24 1998-04-24 Immunhæmmende effekter af 8-substituerede xanthin-derivater DK0956855T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP98201323A EP0956855B1 (en) 1998-04-24 1998-04-24 Immunosuppressive effects of 8 substituted xanthine derivatives

Publications (1)

Publication Number Publication Date
DK0956855T3 true DK0956855T3 (da) 2003-07-14

Family

ID=8233642

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98201323T DK0956855T3 (da) 1998-04-24 1998-04-24 Immunhæmmende effekter af 8-substituerede xanthin-derivater

Country Status (5)

Country Link
EP (1) EP0956855B1 (da)
AT (1) ATE234099T1 (da)
DE (1) DE69812070T2 (da)
DK (1) DK0956855T3 (da)
ES (1) ES2189079T3 (da)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7276506B2 (en) 1998-12-28 2007-10-02 4 Aza Bioscience Nv Immunosuppressive effects of pteridine derivatives
WO2000039129A1 (en) * 1998-12-28 2000-07-06 K.U. Leuven Research & Development Immunosuppressive effects of pteridine derivatives
US7125993B2 (en) * 2001-11-09 2006-10-24 Cv Therapeutics, Inc. A2B adenosine receptor antagonists
US7317017B2 (en) 2002-11-08 2008-01-08 Cv Therapeutics, Inc. A2B adenosine receptor antagonists
US7304070B2 (en) 2001-11-09 2007-12-04 Cv Therapeutics, Inc. A2B adenosine receptor antagonists
AU2002359365B2 (en) 2001-11-09 2008-07-10 Gilead Sciences, Inc. A2B adenosine receptor antagonists
MXPA03008967A (es) 2002-02-01 2004-02-12 King Pharmaceuticals Res & Dev Antagonistas receptores de 8-heteroarilo xantina adenosina a-2b.
US7202257B2 (en) 2003-12-24 2007-04-10 Deciphera Pharmaceuticals, Llc Anti-inflammatory medicaments
US7279576B2 (en) 2002-12-31 2007-10-09 Deciphera Pharmaceuticals, Llc Anti-cancer medicaments
US7144911B2 (en) 2002-12-31 2006-12-05 Deciphera Pharmaceuticals Llc Anti-inflammatory medicaments
CA2524778C (en) * 2003-05-06 2013-01-29 Cv Therapeutics, Inc. Xanthine derivatives as a2b adenosine receptor antagonists
AU2011202523B2 (en) * 2003-11-21 2013-05-30 Gilead Sciences, Inc. A2B adenosine receptor antagonists
EP2942349A1 (en) 2004-12-23 2015-11-11 Deciphera Pharmaceuticals, LLC Enzyme modulators and treatments
WO2008009079A2 (en) 2006-07-20 2008-01-24 Gilead Sciences, Inc. Substituted pteridines useful for the treatment and prevention of viral infections
US8188113B2 (en) 2006-09-14 2012-05-29 Deciphera Pharmaceuticals, Inc. Dihydropyridopyrimidinyl, dihydronaphthyidinyl and related compounds useful as kinase inhibitors for the treatment of proliferative diseases
US7790756B2 (en) 2006-10-11 2010-09-07 Deciphera Pharmaceuticals, Llc Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases
CN101878031A (zh) 2007-04-20 2010-11-03 迪赛孚尔制药有限公司 用于治疗骨髓增生性疾病和其他增生性疾病的激酶抑制剂
US8871751B2 (en) 2008-01-18 2014-10-28 The Board Of Trustees Of The University Of Illinois Compositions and methods relating to nuclear hormone and steroid hormone receptors including inhibitors of estrogen receptor alpha-mediated gene expression and inhibition of breast cancer
EA201170627A1 (ru) 2008-10-29 2011-10-31 ДЕСИФЕРА ФАРМАСЬЮТИКАЛЗ, ЭлЭлСи Циклопропанамиды и аналоги, проявляющие противораковые и антипролиферативные активности
US8461179B1 (en) 2012-06-07 2013-06-11 Deciphera Pharmaceuticals, Llc Dihydronaphthyridines and related compounds useful as kinase inhibitors for the treatment of proliferative diseases
BR112017007194B1 (pt) 2014-10-09 2023-11-07 Guangdong Raynovent Biotech Co., Ltd Compostos de hidroxil purina e uso dos mesmos
CN111233863B (zh) * 2014-10-09 2022-10-25 广东众生睿创生物科技有限公司 羟基嘌呤类化合物及其应用
KR102335970B1 (ko) 2015-03-04 2021-12-07 길리애드 사이언시즈, 인코포레이티드 톨 유사 수용체 조정제 화합물
EP3507288B1 (en) 2016-09-02 2020-08-26 Gilead Sciences, Inc. 4,6-diamino-pyrido[3,2-d]pyrimidine derivaties as toll like receptor modulators
CA3035346A1 (en) 2016-09-02 2018-03-08 Gilead Sciences, Inc. Toll like receptor modulator compounds
CN110041330B (zh) * 2018-01-16 2020-08-11 新发药业有限公司 一种伊曲茶碱的环保制备方法
TW202210480A (zh) 2019-04-17 2022-03-16 美商基利科學股份有限公司 類鐸受體調節劑之固體形式
TWI751517B (zh) 2019-04-17 2022-01-01 美商基利科學股份有限公司 類鐸受體調節劑之固體形式
TW202115056A (zh) 2019-06-28 2021-04-16 美商基利科學股份有限公司 類鐸受體調節劑化合物的製備方法
KR20220045189A (ko) 2019-08-12 2022-04-12 데시페라 파마슈티칼스, 엘엘씨. 위장관 기질 종양을 치료하는 방법
WO2021030405A1 (en) 2019-08-12 2021-02-18 Deciphera Pharmaceuticals, Llc Ripretinib for treating gastrointestinal stromal tumors
CN110922363A (zh) * 2019-12-28 2020-03-27 新华制药（寿光）有限公司 一种紫脲酸连续化生产工艺
CA3163053A1 (en) 2019-12-30 2021-07-08 Michael D. Kaufman Amorphous kinase inhibitor formulations and methods of use thereof
EP4084779A1 (en) 2019-12-30 2022-11-09 Deciphera Pharmaceuticals, LLC Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluorophenyl)-3-phenylurea
US11779572B1 (en) 2022-09-02 2023-10-10 Deciphera Pharmaceuticals, Llc Methods of treating gastrointestinal stromal tumors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0490181A1 (en) * 1990-11-30 1992-06-17 Hoechst-Roussel Pharmaceuticals Incorporated Use of xanthines for preparation of a medicament having immunosuppressing activity
JPH11505241A (ja) * 1995-05-19 1999-05-18 カイロサイエンス・リミテッド キサンチン類およびこれらの治療的使用

Also Published As

Publication number Publication date
ATE234099T1 (de) 2003-03-15
EP0956855B1 (en) 2003-03-12
DE69812070T2 (de) 2003-12-11
DE69812070D1 (de) 2003-04-17
ES2189079T3 (es) 2003-07-01
EP0956855A1 (en) 1999-11-17

Similar Documents

Publication Publication Date Title
DK0956855T3 (da) Immunhæmmende effekter af 8-substituerede xanthin-derivater
NO933452L (no) Et terapeutisk middel for Parkinson's sykdom
ATE282614T1 (de) Phenylharnstoff und phenylthioharnstoffderivate
ES2082805T3 (es) Derivados de tiazol, procedimientos para su produccion y composiciones farmaceuticas que comprenden los mismos.
ES2065895T3 (es) 2-aminobenzotiazoles sustituidos y derivados de los mismos utiles como agentes cerebrovasculares.
HUP0001607A2 (hu) Tienopirimidinszármazékok, e vegyületeket tartalmazó gyógyászati készítmények, eljárás ezek előállítására, valamint e vegyületek alkalmazása
HUP0204526A2 (hu) 2-Oxo-1-pirrolidin-származékok, eljárás előállításukra és alkalmazásuk
DE3854294D1 (de) Bis(acyloxymethyl)imidazol-Derivate.
ES2167676T3 (es) Resinas epoxi ignifugas y agentes ignifugantes para resinas epoxi.
IL129824A (en) Pharmaceutical compositions comprising 2-amino-1,3-propanediol derivatives for preventing and/or treating chronic rejection in a recipient for organ or tissue allo- or xenotransplants
DK0790987T3 (da) Aminotetrazol-derivater, der er anvendelige som nitrogenoxidsynthaseinhibitorer
HUT46313A (en) Process for producing 3/2h/-pyridazine derivatives and pharmaceutical compositions containing them as active components
SE8500877L (sv) Nya enkafalinderivat
BR1100636A (pt) Agente terapêutico para o mal de parkinson, e, derivado da xantina
ATE153664T1 (de) Imidazoacridine und ihre antineoplastische anwendung
ES2110977T3 (es) Espiro-isoquinolein-pirrolidinas y analogos de las mismas, utiles como inhibidores de la aldosa-reductasa.
ES2043834T3 (es) Un procedimiento para preparar nuevos derivados de androsta-1,4-dien-3-ona sustituida en la posicion 17.
YU5199A (sh) Farmaceutski proizvodi za lečenje i sprečavanje bolesti nastalih od oštećenja vaskularnih endotelialnih ćelija
ES2061785T3 (es) Benzopiranos 2,2-disustituidos de utilidad como antagonistas de leucotrieno-d4.
DK384485D0 (da) 1,6-naphthyridinderivater med kardilaterende virkning
HUP0003861A2 (hu) Kinolin-4-il-származékok, eljárás előállításukra és a vegyületeket tartalmazó gyógyászati készítmények
KR910000150A (ko) 대사성 골 질환 치료제
HUP0204278A2 (hu) Nem peptid szubsztituált benzotiazepinszármazékok, mint vazopresszin antagonisták, eljárás az előállításukra, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
EA200200462A1 (ru) Производные 2-арилхинолина, их получение и терапевтическое применение
TH31604A (th) อนุพันธ์ของไอโซอินโดล วิธีการเตรียมและการใช้อนุพันธ์ของไอโซอินโดลให้เป็นประโยชน์ในการบำบัดรักษาโรค